Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

140 ARTÍCULOS , VIENDO DEL 121 AL 135

Emerging concepts in Alzheimer's disease

Vinters HV.

Annu Rev Pathol. 2015;10:291-319. doi: 10.1146/annurev-pathol-020712-163927. Epub 2014 Oct 29.

Amyloid-beta and depression in healthy older adults: a systematic review

Harrington KD, Lim YY, Gould E, Maruff P.

Aust N Z J Psychiatry. 2015 Jan;49(1):36-46. doi: 10.1177/0004867414557161. Epub 2014 Nov 20.

Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease

Schaffer C, Sarad N, DeCrumpe A, Goswami D, Herrmann S, Morales J, Patel P, Osborne J.

J Lab Autom. 2015 Oct;20(5):589-600. doi: 10.1177/2211068214559979. Epub 2014 Nov 25.

Targeting microglia for the treatment of Alzheimer's disease

McGeer PL, McGeer EG.

Expert Opin Ther Targets. 2015 Apr;19(4):497-506. doi: 10.1517/14728222.2014.988707. Epub 2014 Nov 29.

Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease

Rueda AD, Lau KM, Saito N, Harvey D, Risacher SL, Aisen PS, Petersen RC, Saykin AJ, Farias ST; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Sep;11(9):1080-9. doi: 10.1016/j.jalz.2014.09.002. Epub 2014 Nov 15.

Leisure activities, apolipoprotein E e4 status, and the risk of dementia

Yang SY, Weng PH, Chen JH, Chiou JM, Lew-Ting CY, Chen TF, Sun Y, Wen LL, Yip PK, Chu YM, Chen YC.

J Formos Med Assoc. 2015 Dec;114(12):1216-24. doi: 10.1016/j.jfma.2014.09.006. Epub 2014 Nov 4.

Biomarkers, ketone bodies, and the prevention of Alzheimer's disease

VanItallie TB.

Metabolism. 2015 Mar;64(3 Suppl 1):S51-7. doi: 10.1016/j.metabol.2014.10.033. Epub 2014 Oct 30.

Biomarkers in the diagnosis and management of Alzheimer's disease

Wurtman R.

Metabolism. 2015 Mar;64(3 Suppl 1):S47-50. doi: 10.1016/j.metabol.2014.10.034. Epub 2014 Oct 30.

Amyloid-beta: a crucial factor in Alzheimer's disease

Sadigh-Eteghad S, Sabermarouf B, Majdi A, Talebi M, Farhoudi M, Mahmoudi J.

Med Princ Pract. 2015;24(1):1-10. doi: 10.1159/000369101. Epub 2014 Nov 27.

Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort

Teng E, Chow N, Hwang KS, Thompson PM, Gylys KH, Cole GM, Jack CR Jr, Shaw LM, Trojanowski JQ, Soares HD, Weiner MW, Apostolova LG; Alzheimer’s Disease Neuroimaging Initiative.

Dement Geriatr Cogn Disord. 2015;39(3-4):154-66. doi: 10.1159/000368982. Epub 2014 Dec 24.

Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective

Lewczuk P, Mroczko B, Fagan A, Kornhuber J.

Adv Med Sci. 2015 Mar;60(1):76-82. doi: 10.1016/j.advms.2014.11.002. Epub 2014 Dec 9.

Are blood-based protein biomarkers for Alzheimer's disease also involved in other brain disorders? A systematic review

Chiam JT, Dobson RJ, Kiddle SJ, Sattlecker M.

J Alzheimers Dis. 2015;43(1):303-14. doi: 10.3233/JAD-140816.

Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation

Shi M, Movius J, Dator R, Aro P, Zhao Y, Pan C, Lin X, Bammler TK, Stewart T, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Zhang J.

Mol Cell Proteomics. 2015 Mar;14(3):544-55. doi: 10.1074/mcp.M114.040576. Epub 2015 Jan 2.

The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease

Dursun E, Gezen-Ak D, Hanağası H, Bilgiç B, Lohmann E, Ertan S, Atasoy İL, Alaylıoğlu M, Araz ÖS, Önal B, Gündüz A, Apaydın H, Kızıltan G, Ulutin T, Gürvit H, Yılmazer S.

J Neuroimmunol. 2015 Jun 15;283:50-7. doi: 10.1016/j.jneuroim.2015.04.014. Epub 2015 Apr 25.

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):865-84. doi: 10.1016/j.jalz.2015.04.005.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias